Hyderabad, Telangana Jul 14, 2021 (Issuewire.com) - Sandor recently introduced an innovative and state-of-the-art SARS-CoV-2 Test with a gold-standard RT-PCR detection of the Coronavirus in a point-of-care format. Thermo Fisher Scientific’s Accula is an easy-to-use test with procedural knowledge of conventional rapid immunoassays.
Accula system from Thermo Fisher Scientific has received the ‘Emergency Use Authorization’ (EUA) from the USA’s Food and Drug Administration (FDA) for SARS-CoV-2 detection in a clinical laboratory.
The palm-sized dock uses nasal swab samples and provides qualitative & reliable results in 30 minutes. The Accula test is enabled by PCR technology that permits the reduced absolute temperatures and reduced temperature differentials which results in rapid exponential amplification. No dedicated storage or transportation equipment is required as well.
Since the beginning of this pandemic, Thermo Fisher Scientific has constantly struck back to assist scientists and healthcare workers, fighting at the frontline.
ABOUT SANDOR MEDICAIDS
Sandor Medicaids thrives on bringing the best healthcare solutions to serve humanity and upgrade the Indian Healthcare Industry through modern products and appliances.
Since Sandor’s inception in 1995, it has strived to bring high-tech biomedical and biotechnology products to India.
Sandor has been the first company to bring the “Point of Care” concept to the Indian ICUs. Sandor has over 20 branches with an efficient and reliable distribution systems, making it a leading choice for the launch of newer & latest medical devices and equipment.
Media Contact
Sandor Medicaids info@sandor.co.in 040-23357048 8-2, 326/5, Rd Number 3, Green Valley, Banjara Hills, Hyderabad, Telangana 500034 https://sandor.co.in/
